{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Possible Case of Opioid-Induced Hypoglycemia and the Potential Role of Naloxone

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain the physiological effects of opioids and naloxone on blood glucose levels.
  2. Identify opioids that may cause hypoglycemia.
  3. Describe the management of a patient with opioid-induced hypoglycemia.
  4. Identify a drug of abuse that may cause hyperglycemia.

Learning Outcomes

Seventy-five percent of participants will demonstrate competency in clinical reasoning regarding the care of a patient with opioid-induced hypoglycemia by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $24.95


  • ANCC 2.5 CH / 2.5 APH
  • DC - BON 2.5 CH
  • FL - BON 2.5 CH
  • GA - BON 2.5 CH
  • NM - BON 2.5 CH
  • SC - BON 2.5 CH
  • WV - BOERN 2.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: AENJ0423A
Published: Apr/Jun 2023
Expires: 3/6/2026
Required Passing Score: 7/9 (77%)
Authors: Kyle A. Weant, PharmD, BCPS, BCCCP, FCCP; Kyle E. Embertson, MD; Daniel W. Fisher, DO